2023
Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis
Aghaei A, Gholami J, Sangchooli A, Rostam-Abadi Y, Olamazadeh S, Ardeshir M, Baheshmat S, Shadloo B, Taj M, Saeed K, Rahimi-Movaghar A. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis. The Lancet Global Health 2023, 11: e1225-e1237. PMID: 37474230, DOI: 10.1016/s2214-109x(23)00267-x.Peer-Reviewed Original ResearchConceptsPrevalence of injection drug useInjection drug usePrevalence of HIVHepatitis B virusHepatitis C virusB virusC virusMeta-analysisSystematic reviewHepatitis C virus infection ratesEastern Mediterranean RegionCharacteristics of peopleDrug useHIV infection ratesOpioid agonist treatmentInfection rateProgramme servicesPopulation size of peopleHepatitis CAgonist treatmentHarm reduction servicesHepatitis BWHO Eastern Mediterranean RegionWeb of ScienceProvision of services
2020
Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis
Rostam-Abadi Y, Rafiemanesh H, Gholami J, Shadloo B, Amin-Esmaeili M, Rahimi-Movaghar A. Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis. Harm Reduction Journal 2020, 17: 81. PMID: 33087141, PMCID: PMC7579800, DOI: 10.1186/s12954-020-00424-w.Peer-Reviewed Original ResearchConceptsHepatitis B virusHepatitis B virus infectionPrevalence of HBV infectionHepatitis B virus prevalenceHBV infectionSubgroups of PWIDHepatitis B virus surface antigenB virus infectionRandom-effects model meta-analysisMeta-analysisPrevalence of HBsAgEstimation of HBsAgHigh-risk groupSystematic reviewPooled prevalence of HBsAgHarm reduction interventionsMeta-regression analysisPositive HBsAgHistory of imprisonmentHBsAg prevalenceB virusConclusionThe prevalenceReduction interventionsAt-risk populationsHBsAg